VRTX vs VSTD
Vertex Pharmaceuticals Inc (VRTX) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
VRTX currently screens at market cap $106.87B and trailing P/E 29.7. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the VRTX and VSTD stock pages for the full models.
Not investment advice.